미국 FDA

[US, FDA] Artificial Intelligence and Machine Learning in Software as a Medical Device

MD우야 2024. 3. 29. 09:00
반응형

Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together

The U.S. Food and Drug Administration (FDA) issued "Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together," which outlines the agency's commitment and cross-center collaboration to protect public health while fostering responsible and ethical medical product innovation through Artificial Intelligence.

 

 

Artificial Intelligence and Machine Learning in Software as a Medical Device | FDA

 

Artificial Intelligence and Machine Learning in Software

Medical device manufacturers are using these technologies to innovate their products to better assist health care providers and improve patient care.

www.fda.gov

반응형

'미국 FDA' 카테고리의 다른 글

[US, FDA] CDRH Issues Guiding Principles for Transparency of Machine Learning-Enabled Medical Devices  (0) 2024.06.21
[US, FDA] U.S. FDA IVD Reclassification Announcement for Laboratory Developed Tests  (0) 2024.02.27
[FDA] Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile  (0) 2024.01.12
[FDA] US FDA moves to electronic formats for medical device export documents  (0) 2024.01.08
[FDA voices] Increasing options in clinical research to facilitate medical product development  (1) 2023.12.24

'미국 FDA'의 다른글

  • 현재글[US, FDA] Artificial Intelligence and Machine Learning in Software as a Medical Device

관련글

티스토리툴바